Business

Philip Morris International Announces U.S. FDA Reauthorization of IQOS as a Modified Risk Tobacco Product

STAMFORD, CT, April 17, 2026--The U.S. Food and Drug Administration (FDA) announced that it has authorized the renewal of modified risk tobacco product (MRTP) orders previously granted to PMI for two versions of the IQOS device and three variants of the tobacco consumables, commercialized under the HEETS brand. This renewal allows PMI to continue sharing reduced-exposure information with U.S. adults 21+ who use traditional tobacco products, such as combustible cigarettes.

articlePicard Medical, Inc.April 17, 20268/company/picard-medical-inc/news/philip-morris-international-announces-us-fda-reauthorization-of-iqos-as-a-modified-risk-tobacco-product-1
Philip Morris International Announces U.S. FDA Reauthorization of IQOS as a Modified Risk Tobacco Product

About this update from Picard Medical, Inc.

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":3543,"height":612,"url":"https://media.zenfs.com/en/business-wire.com/e61a73d232df1e4c05cba8c4f3474148"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/E1hZAtJwWzlDsA.9LkiHHA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTE2Ng--/https://media.zenfs.com/en/business-wire.com/e61a73d232df1e4c05cba8c4f3474148","width":960,"height":166},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/vtXgI0imDqlg01V_cdKTlQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD00MTQ-/https://media.zenfs.com/en/business-wire.com/e61a73d232df1e4c05cba8c4f3474148","width":1200,"height":207}},"lazy":false},{"type":"text","content":"A pioneer in smoke-free tobacco products, Philip Morris International is the only company that has received modified risk tobacco product authorizations for heated tobacco products.","length":181,"tagName":"p","attribs":{}},{"type":"text","content":"In their order, FDA concluded that: "Scientific studies have shown that switching completely from conventional cigarettes to the IQOS system significantly reduces your body’s exposure to harmful or potentially harmful chemicals"","length":238,"tagName":"p","attribs":{}},{"type":"text","content":"STAMFORD, CT, April 17, 2026--(BUSINESS WIRE)--The U.S. Food and Drug Administration (FDA) announced that it has authorized the renewal of modified risk tobacco product (MRTP) orders previously granted to PMI for two versions of the IQOS device and three variants of the tobacco consumables, commercialized under the HEETS brand. This renewal allows PMI to continue sharing reduced-exposure information with U.S. adults 21+ who use traditional tobacco products, such as combustible cigarettes.","length":493,"tagName":"p"},{"type":"text","content":"The agency concluded that renewing the IQOS and HEETS MRTP authorizations is appropriate to promote public health and is expected to benefit the health of the population as a whole taking into account both users of tobacco products and persons who do not currently use tobacco products.","length":286,"tagName":"p"},{"type":"text","content":""As the only company to have successfully secured and maintained MRTP authorizations for heated tobacco products in the U.S., we are confident that our science-based alternatives can help adult...

More updates from Picard Medical, Inc.

IQOStobacco productsPhilip Morris InternationalFood and Drug Administrationpublic healthheated tobaccoMRTPmodified risk tobacco product